Multiple Sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system with a complex pathophysiology. According to WHO Atlas of MS 2013 estimated a prevalence rate of 5-20 per 100,000 population. The number has raised drastically in India in recent years. Estimates range from between 100,000 and 200,000 such patients throughout the country and worldwide it is 3 million.

Although Multiple Sclerosis (MS) is difficult to cure in early stages it can be cured. It becomes incurable after myelin is lost or damaged completely, but possible to manage. Early treatment approach with our special protocol can reverse the pathology. Depending on the person it can be cured or managed effectively. It is always advisable to start with the protocol within the first two years to achieve best results in primary progressive and progressive relapsing sub-types treatment.  

At this time, there is no definite laboratory tests nor physical findings and symptoms to determine if a person has Multiple Sclerosis (MS). Therefore several strategies have been developed to determine whether the patient meets the long term criteria for Multiple Sclerosis (MS) and further other possible causes to the symptoms the person is experiencing should also be ruled out.

MRI – BRAIN or SPINAL CORD

SPINAL TAP

EVOKED POTENTIALS

The symptoms of MS varies from person to person also changes during the course of its progression based on the location of affected nerve fibre. The commonly seen symptoms are as follows:

Bladder Problems:

Bowel Problems:

Cognitive Changes:

Depression:

Dizziness or Vertigo:

Emotional Changes:

Fatigue:

Numbness or Tingling:

Pain:

Sexual Problem:

Spasticity:

Vision problems:

Walking or Gait difficulties:

Multiple sclerosis (MS) is an autoimmune inflammatory demyelinating disease of the central nervous system. It has been well known in the West since its first description by Charcot in 1868. In India, the disease came to be recognized only in the 1960s when physicians who received training in Neurology in the West, returned to India. Baldev Singh, Bharucha and Ramamurthy were the ones who first described the manifestations of MS in Indian context.

There are a large number of identifiable motor neuron diseases and demyelinating diseases. Among the most common diseases of these types is MS. Multiple sclerosis(MS) is a frequent and disabling neurological disease characterized by multifocal destruction of central nervous system myelin.

Myelin is a series of concentric membranes surrounding an axon like insulation surrounding a wire.   The myelin is formed by Schwann cell in the peripheral nervous system. Large diameter nerve fibers are surrounded by an insulation of membrane known as myelin. Myelin, as well as the number of nodes of Ranvier are proportionately related to the speed of an impulse along a nerve fiber.

According to article published by  Annals, Academy of Medicine, Singapore (AAMS) on January 14, 1985 by Singhal B.S. the approximate prevalence rate of MS in India was between 0.17 to 1.33 per 100,000 of population in different parts of India. And the mean onset of MS for MS patients was 27.7 years with high incidence of optic nerve involvement, both at the onset and duing the course of the disease.

The prevalence of MS in Europe is approximately 1/2000 inhabitants (Noseworthy et al., 2000). The disease typically begins between the ages of 20 and 30 and affects twice as many women as men. In 80% of cases, the disease initially evolves through attacks which result completely or with sequalae in a few weeks or months (pure remitting phase or emitting phase with sequalae). However, in 40% to 70% of cases, patients who experience an initially remitting evolvement subsequently evolve towards a progressive form (secondary progressive form). In 20% of patients, the evolvement is immediately progressive without attacks (primary progressive form).